Skvarka, a director at Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), has purchased 60,000 shares of the company's common stock, according to a recent SEC filing. This insider purchase comes as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback